Acceso abierto

Parathyroidectomy in a patient treated with emicizumab

Helen Hupston

Helen Hupston

University Hospital, Queen Elizabeth Hospital BirminghamBirmingham, UK
Perfil de Orcid
Buscar este autor en
Sciendo|Google Scholar
Hupston, Helen
  
23 dic 2019
Parathyroidectomy in a patient treated with emicizumab's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Publicado en línea: 23 dic 2019
Páginas: 51 - 53
DOI: https://doi.org/10.17225/jhp00149
Palabras clave
© 2019 Helen Hupston, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
Idioma:
Inglés
Calendario de la edición:
1 veces al año
Temas de la revista:
Medicina, Ciencias médicas básicas, Ciencias médicas básicas, otros, Medicina Clínica, Medicina Clínica, otros, Farmacia, Farmacología
RSS Feed de revista